Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials

Pigment Cell and Melanoma Research · Published 2026-07-01 · DOI 10.1111/pcmr.70109

Authors (4)

Hitaishi Mehta, Muthu Sendhil Kumaran, Davinder Parsad, Keshavamurthy Vinay

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mehta, H., Kumaran, M., Parsad, D., et al. (2026). Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials. Pigment Cell and Melanoma Research. https://doi.org/10.1111/pcmr.70109

Related articles

• Development of Poliosis in Patients Treated With Immunotherapy for Metastatic Cutaneous and Non‐Cutaneous Melanoma · Pigment Cell and Melanoma Research · 2026 · Same journal
• MelOD : The Melanoma Omics Dashboard for Multimodal Data Exploration · Pigment Cell and Melanoma Research · 2026 · Same journal
• Histopathological Analysis Revealed Melanosome‐Retaining Fibroblasts and Autophagy‐Impaired Macrophages in Ashy Dermatosis · Pigment Cell and Melanoma Research · 2026 · Same journal
• A New Era in Leptomeningeal Disease ( LMD ): Recent Advancements in Immunocellular and Radiation Therapies in Melanoma LMD , What Has Been Done and Future Directions · Pigment Cell and Melanoma Research · 2026 · Same journal
• Copy Number Analysis in Congenital Nevi: Concordance and Diagnostic Limitations of aCGH , sWGS , and Methylation Sequencing · Pigment Cell and Melanoma Research · 2026 · Same journal
• Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA ‐Based Anchored Multiplex Polymerase Chain Reaction · Pigment Cell and Melanoma Research · 2025 · Same journal
• Development and Validation of Vitiligo‐Specific‐Belief About Therapy Questionnaire (BTQ‐Vitiligo) · Pigment Cell and Melanoma Research · 2025 · Same journal
• Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma · Pigment Cell and Melanoma Research · 2026 · Same journal
• A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility · Pigment Cell and Melanoma Research · 2026 · Same journal
• Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan‐Induced DNA Double‐Strand Breaks in Uveal Melanoma · Pigment Cell and Melanoma Research · 2026 · Same journal